+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Artificial Organ Market 2018-2022 - Product Image

Global Artificial Organ Market 2018-2022

  • ID: 4600474
  • Report
  • June 2018
  • Region: Global
  • 127 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • Baxter
  • Boston Scientific
  • Cochlear
  • F. Hoffmann-La Roche
  • Fresenius Medical Care
  • MORE
About Artificial Organs

Artificial organs are man-made devices or implants meant to replace damaged natural organs. An artificial organ mimics a natural organ, performs its normal functions, and increases the life expectancy of the recipient. Artificial organs are incorporated with different technologies such as sensors, biomaterials, and innovative delivery systems.

The analysts forecast the global artificial organs market to grow at a CAGR of 9.56% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global artificial organs market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Artificial Organs Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott
  • Baxter
  • Boston Scientific
  • Cochlear
  • F. Hoffmann-La Rache
  • Fresenius Medical Care
  • Medtronic
Market drivers
  • Increasing prevalence of chronic disorders
  • For a full, detailed list, view the full report
Market challenges
  • Complications and limitations of artificial organs
  • For a full, detailed list, view the full report
Market trends
  • Emergence of TAH
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Baxter
  • Boston Scientific
  • Cochlear
  • F. Hoffmann-La Roche
  • Fresenius Medical Care
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 05: MARKET SIZING
  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
  • Segmentation by product
  • Comparison by product
  • Artificial heart - Market size and forecast 2017-2022
  • Artificial kidney - Market size and forecast 2017-2022
  • Cochlear implants - Market size and forecast 2017-2022
  • Artificial pancreas - Market size and forecast 2017-2022
  • Market opportunity by product
PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY END-USER
  • Segmentation by end-user
  • Hospitals and clinics
  • ASCs
  • Dialysis centers
  • Others
PART 10: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity
PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 13: MARKET TRENDS
  • Emergence of TAH
  • Technological advances in artificial organs
  • Growing popularity of home hemodialysis
  • New product launches
PART 14: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 15: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Baxter
  • Boston Scientific
  • Cochlear
  • F. Hoffmann-La Roche
  • Fresenius Medical Care
  • Medtronic
PART 16: APPENDIX
  • List of abbreviations
List of Exhibits
Exhibit 01: Parent market
Exhibit 02: Global artificial organs and bionics market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global artificial organs - Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global artificial organs market - Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Product - Market share 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Artificial heart - Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Artificial heart - Year-over-year growth 2018-2022 (%)
Exhibit 22: Artificial kidney - Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Artificial kidney - Year-over-year growth 2018-2022 (%)
Exhibit 24: Cochlear implants - Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Cochlear implants - Year-over-year growth 2018-2022 (%)
Exhibit 26: Artificial pancreas - Market size and forecast 2017-2022 ($ mn)
Exhibit 27: Artificial pancreas - Year-over-year growth 2018-2022 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Customer landscape
Exhibit 30: Market share by end-user 2017-2022 (%)
Exhibit 31: Global artificial organs - Market share by geography 2017-2022 (%)
Exhibit 32: Regional comparison
Exhibit 33: Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 34: Americas - Year-over-year growth 2018-2022 (%)
Exhibit 35: Top 3 countries in Americas
Exhibit 36: EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 37: EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 38: Top 3 countries in EMEA
Exhibit 39: APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 40: APAC - Year-over-year growth 2018-2022 (%)
Exhibit 41: Top 3 countries in APAC
Exhibit 42: Market opportunity
Exhibit 43: Recent product recalls
Exhibit 44: Product launches and their market impact analysis
Exhibit 45: Vendor landscape
Exhibit 46: Landscape disruption
Exhibit 47: Vendors covered
Exhibit 48: Vendor classification
Exhibit 49: Market positioning of vendors
Exhibit 50: Abbott - Overview
Exhibit 51: Abbott - Business segments
Exhibit 52: Abbott - Organizational developments
Exhibit 53: Abbott - Geographic focus
Exhibit 54: Abbott - Segment focus
Exhibit 55: Abbott - Key offerings
Exhibit 56: Abbott - Key customers
Exhibit 57: Baxter - Overview
Exhibit 58: Baxter - Business segments
Exhibit 59: Baxter - Organizational developments
Exhibit 60: Baxter - Geographic focus
Exhibit 61: Baxter - Segment focus
Exhibit 62: Baxter - Key offerings
Exhibit 63: Baxter - Key customers
Exhibit 64: Boston Scientific - Vendor overview
Exhibit 65: Boston Scientific - Business segments
Exhibit 66: Boston Scientific - Organizational developments
Exhibit 67: Boston Scientific - Geographic focus
Exhibit 68: Boston Scientific - Segment focus
Exhibit 69: Boston Scientific - Key offerings
Exhibit 70: Boston Scientific- Key customers
Exhibit 71: Cochlear - Overview
Exhibit 72: Cochlear - Business segments
Exhibit 73: Cochlear - Organizational developments
Exhibit 74: Cochlear - Geographic focus
Exhibit 75: Cochlear - Segment focus
Exhibit 76: Cochlear - Key offerings
Exhibit 77: Cochlear - Key customers
Exhibit 78: F. Hoffmann-La Roche - Overview
Exhibit 79: F. Hoffmann-La Roche - Business segments
Exhibit 80: F. Hoffmann-La Roche - Organizational developments
Exhibit 81: F. Hoffmann-La Roche - Geographic focus
Exhibit 82: F. Hoffmann-La Roche - Segment focus
Exhibit 83: F. Hoffmann-La Roche - Key offerings
Exhibit 84: F. Hoffmann-La Roche - Key customers
Exhibit 85: Fresenius Medical Care - Overview
Exhibit 86: Fresenius Medical Care - Business segments
Exhibit 87: Fresenius Medical Care - Organizational developments
Exhibit 88: Fresenius Medical Care - Geographic focus
Exhibit 89: Fresenius Medical Care - Segment focus
Exhibit 90: Fresenius Medical Care - Key offerings
Exhibit 91: Fresenius Medical Care - Key customers
Exhibit 92: Medtronic - Overview
Exhibit 93: Medtronic - Business segments
Exhibit 94: Medtronic - Organizational developments
Exhibit 95: Medtronic - Geographic focus
Exhibit 96: Medtronic - Segment focus
Exhibit 97: Medtronic - Key offerings
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott
  • Baxter
  • Boston Scientific
  • Cochlear
  • F. Hoffmann-La Roche
  • Fresenius Medical Care
  • MORE
New Report Released: - Global Artificial Organs Market 2018-2022.

The author of the report recognizes the following companies as the key players in the global artificial organs market: Abbott, Baxter, Boston Scientific, Cochlear, F. Hoffmann-La Rache, Fresenius Medical Care, and Medtronic.

Commenting on the report, an analyst from the research team said: “One trend in the market is emergence of TAH. Total artificial hearts have emerged as an effective treatment option for patients with end-stage biventricular heart failure, awaiting orthotopic heart transplantation. Their use as an intermediate to heart transplantation was recently approved globally.”

According to the report, one driver in the market is increasing prevalence of chronic disorders. The increase in the prevalence of cardiovascular diseases (CVDs) such as strokes and cardiac diseases, diabetes, chronic kidney diseases, and hearing disorders and rise in aging population are likely to increase the demand for artificial organs.

Further, the report states that one challenge in the market is complications and limitations of artificial organs. The purpose of artificial organs is to replace the damaged or diseased organ so that functions of the replaced organ are restored. Though artificial organs can save the life of a person, their benefit is not as apparent as it may seem.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Abbott
  • Baxter
  • Boston Scientific
  • Cochlear
  • F. Hoffmann-La Roche
  • Fresenius Medical Care
  • Medtronic
Note: Product cover images may vary from those shown
Adroll
adroll